Form 4 for NHC NATIONAL HEALTHCARE CORP
Accepted 2024-05-01 00:00:00 ET · period of report 2024-04-30 · accession 0001437749-24-014187 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-01 | 2024-04-30 | NHC | LAROCHE RICHARD F JR | Dir | M - OptEx | $77.92 | +7,500 | 0 | New | +$584.4K |
| D | 2024-05-01 | 2024-04-30 | NHC | LAROCHE RICHARD F JR | Dir | F - Tax | $90.87 | -3,001 | 200.9K | -1% | -$272.7K |
| DM | 2024-05-01 | 2024-04-30 | NHC | LAROCHE RICHARD F JR | Dir | M - OptEx | $0.00 | -7,500 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (held in my name or my wife's name) | 2024-04-30 | M | A | 3,500 | $77.92 | 0 | D | — | — | (F1) These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). (F2) Transaction totaled on the line below for securities of this title. |
| 2 | Common | Common Stock (held in my name or my wife's name) | 2024-04-30 | M | A | 4,000 | $77.92 | 0 | D | — | — | (F1) These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). (F2) Transaction totaled on the line below for securities of this title. |
| 3 | Common | Common Stock (held in my name or my wife's name) | 2024-04-30 | F | D | 3,001 | $90.87 | 200,912 | D | — | — | (F3) Shares were withheld by the Company to pay the exercise price. (F4) Total amount for this title following transactions reported on this form. |
| 4 | Derivative | Option to Purchase Common Stock [2019 Grant] | 2024-04-30 | M | D | 4,000 | $0.00 | 3,500 | D | $77.92 · 2019-05-09 to 2024-05-08 | 7,500 Common Stock | (F1) These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |
| 5 | Derivative | Option to Purchase Common Stock [2019 Grant] | 2024-04-30 | M | D | 3,500 | $0.00 | 0 | D | $77.92 · 2019-05-09 to 2024-05-08 | 3,500 Common Stock | (F1) These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). |